RxDoctor Payments Data

Jason Poston, MD

Pain Medicine · Idaho Falls, IDNPI 1457527772

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Relievant Medsystems, Inc. at 27.5% of the total. Reporting peaked in 2022 at $3,677 and has fallen 87.7% since, to $452 in 2025.

$10,602in general payments, 2019–2025

Across 391 payments — averaging $27.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$3K
  • Boston Scientific$2K
  • Flowonix Medical Incorporated$1K
  • Abbott$1K
  • Surgentec$757
  • Medtronic$714
  • plus $1K from 14 others
$3,074in research payments, 2019–2025

Across 3 payments — averaging $1024.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$3K

What the payments were for

  • Consulting fees$1,46514%
  • Travel & lodging$3,40132%
  • Food & beverage$5,73654%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,602 in reported general payments places this provider in the 80th percentile of 32 pain medicine providers in Idaho.

See all pain medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$239,322
Medicare patients
553
Services billed
2,491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine30$7,542
MovantikNaloxegol Oxalate12$5,628
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen210$4,362
Pregabalin86$3,865
Fentanyl37$3,473
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen118$3,160
Gabapentin147$2,678
Celecoxib38$1,871
Naloxone Hcl19$1,597
Cefadroxil70$1,032
Oxycodone Hcl39$666
Tramadol Hcl91$649
Methadone Hcl21$510
Tizanidine Hcl43$472
Mupirocin74$411

Paid to pharmacies, not to this prescriber.

Other pain medicine in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →